In a world first, medical regulators in the UK have approved a gene therapy that aims to cure sickle cell disease and beta thalassemia.
The treatment is the first to be licensed using the gene-editing tool known as Crispr, for which its discoverers were awarded the Nobel prize in 2020.
It is a revolutionary advance for two inherited blood conditions, both triggered by errors in the gene for haemoglobin.
In trials, 28 out of 29 sickle cell patients were free of severe pain and 39 of 42 beta thalassemia patients no longer needed blood transfusions for at least a year.
The trials are continuing in the UK, US, France, Germany and Italy.
Please subscribe here: http://bit.ly/1rbfUog
#GeneTherapy #SickleCellDisease #BetaThalassemia #BBCNews
L'edizione della notte del Tg diretto da Enrico Mentana
L'informazione della testata giornalistica di LA7 diretta da Enrico Mentana
NAPOLI (ITALPRESS) – Nessun problema per il Napoli di Antonio Conte, che batte 2-0 il Verona e ribadisce il primo…
The authorities in Los Angeles warn that scammers and looters are taking advantage of victims of the wildfires that have…
BOLOGNA (ITALPRESS) – La Roma acciuffa all’ultimo respiro il 2-2 al Dall’Ara contro il Bologna: dopo il vantaggio giallorosso di…
Subscribe here: http://bit.ly/1rbfUog For more news, analysis and features visit: www.bbc.com/news #BBCNews